Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Advances in Clinical Chemistry|August 11, 2022
Biomarkers in cardiogenic shockJohan Lassus, Tuukka Tarvasmäki, Heli TolppanenClinical Cardiology|June 11, 2025
Initial Care Pathway in Acute Heart Failure From Home to HospitalPia Harjola, Veli-Pekka Harjola, Òscar Miró, et al.International Journal of Cardiology|April 25, 2016
Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patientsMatti Kivikko, Piero Pollesello, Tuukka Tarvasmäki, et al.European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapiesTuukka Tarvasmäki, Veli-Pekka Harjola, Jukka Tolonen, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 7, 2021
Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock StudyAntoine Kimmoun, Kevin Duarte, Veli-Pekka Harjola, et al.International Journal of Cardiology|January 19, 2017
The impact of emergency medical services in acute heart failurePia Harjola, James Boyd, Tuukka Tarvasmäki, et al.Journal of Cardiac Failure|August 1, 2014
Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survivalTuukka Tarvasmäki, Veli-Pekka Harjola, Markku S Nieminen, et al.International Journal of Cardiology|October 18, 2012
Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failureJohan P E Lassus, Krista Siirilä-Waris, Markku S Nieminen, et al.European Heart Journal|June 18, 2019
Protein-based cardiogenic shock patient classifierFerran Rueda, Eva Borràs, Cosme García-García, et al.ESC Heart Failure|November 26, 2018
Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shockToni Jäntti, Heli Segersvärd, Heli Tolppanen, et al.Pageof 4